Saol Therapeutics secures up to $115 million from Oaktree to support the launch preparation for SL1009. The funding will also aid in lifecycle expansion into Congenital Lactic Acidosis and other pain indications.
Amount Raised
$115 Million
Round Type
Venture
Investors
Description
Saol Therapeutics has announced a definitive agreement for an investment of up to $115 million from Oaktree. This milestone-based capital will fund the launch readiness for SL1009 and support further development of their portfolio. Additional funds will be released as Saol meets specified regulatory, clinical, and commercial milestones. The financing exemplifies Oaktree's understanding of Saol's long-term potential across its portfolio.
Quick answer
Saol Therapeutics raised $115 Million in a funding round, dated September 15, 2026. Investors: Oaktree.
- How much did Saol Therapeutics raise?
- Saol Therapeutics raised $115 Million in a funding round on September 15, 2026.
- Who invested in Saol Therapeutics?
- Oaktree is named as investors in this round.
- What does Saol Therapeutics do?
- Saol Therapeutics (pronounced "Sail") is a privately held, biopharmaceutical company with operations in Roswell, GA, Dublin, Ireland and Hamilton, Bermuda.
- Where is Saol Therapeutics based and how big is it?
- Fundz records about 34 employees.
- Who are the decision-makers at Saol Therapeutics?
- Fundz holds 2 contacts at Saol Therapeutics, including the Chief Strategy Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Saol Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- MedinCell raised $15M (Debt Financing) on October 13, 2026.
- IMPLICITY raised $41M on September 9, 2026.
- Alzamend Neuro raised $7.5M (Series D) on August 4, 2026.
- Setara Biosciences raised $90M (Series A) on October 30, 2026.
- ABA Life raised $40M on October 30, 2026.
- StimCardio raised $30M (Series A) on October 29, 2026.
Who to call at Saol Therapeutics, and when
A new round usually means Saol Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Saol Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Saol Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Saol Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Saol Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Saol Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.